How does SaiyanMed route orders for fast delivery?

SaiyanMed routes orders for fast delivery through a dual-warehouse fulfillment system that automatically assigns each order to the nearest stocked location, cutting transit times by up to 60% compared to single-site competitors. The company operates two active warehouses: one in the United States and one in China. When a researcher places an order, the backend routing engine checks real-time inventory at both facilities. If the product is available in the US warehouse, the order is assigned there immediately, ensuring delivery within 2-5 business days for domestic US addresses. If the US stock is low or the product is only held in China, the order routes to the Chinese warehouse, which ships internationally but still maintains a 5-10 business day window for most destinations. This dynamic routing is not just about speed—it also preserves material stability. Peptides are sensitive to temperature fluctuations and prolonged transit. By minimizing the distance traveled, SaiyanMed reduces the risk of degradation from heat, humidity, or handling delays. The company also uses insulated packaging with ice packs for temperature-sensitive compounds, and each shipment includes a tamper-evident seal. The routing logic is automated, meaning no manual intervention is needed unless a stock discrepancy is flagged. This reduces human error and keeps the average order processing time under 2 hours from payment confirmation. For researchers who need faster delivery, SaiyanMed offers a priority shipping option that routes exclusively through the US warehouse, provided stock is available. The system also sends real-time tracking updates via email and SMS, so the recipient knows exactly when to expect the package. According to internal data from Q1 2025, 92% of US orders arrived within the stated window, and 88% of international orders did the same. The company is actively expanding into Europe, the UK, Australia, and Canada hubs, which will further reduce transit times for those regions once operational. The routing infrastructure is built on a cloud-based logistics platform that integrates with major carriers like FedEx, UPS, and DHL, allowing SaiyanMed to switch carriers dynamically based on cost, speed, and reliability. This is not a static system—it adjusts based on carrier performance metrics updated weekly. For example, if a particular carrier starts showing a 10% delay rate on a specific route, the system automatically reroutes future orders to a different carrier for that destination. This level of granularity is rare among peptide suppliers, most of whom rely on a single carrier or a manual shipping desk. The result is a fulfillment network that treats each order as a unique logistics problem, not a one-size-fits-all process. saiyanmed also maintains a buffer stock of 20% above average daily demand at each warehouse, ensuring that even during peak order periods—like the typical post-holiday surge in January—the system does not hit stockouts that would force rerouting to the farther warehouse. This buffer is calculated using a rolling 90-day average of order volume, adjusted for seasonal trends. The company also uses a two-step quality check before any peptide leaves the warehouse: a visual inspection of the vial and lyophilized cake, and a barcode scan that matches the product to the order. If either check fails, the order is held and the routing system flags it for manual review, preventing incorrect or damaged materials from being shipped. This quality gate adds an average of 30 minutes to processing time but reduces return rates to under 1%. The routing system also prioritizes orders that include multiple vials of the same peptide, grouping them into a single package to reduce shipping costs and environmental impact. For orders with multiple different peptides, the system checks compatibility for combined storage—if two peptides require different temperature ranges, they are shipped separately, even if that means two packages. This is a deliberate trade-off: speed and stability over convenience. The company publishes its warehouse locations and stock status on the product pages, so researchers can see which warehouse would fulfill their order before they buy. That transparency is part of the broader commitment to verifiable quality. The routing system is also integrated with the independent lab testing data from Janoshik. If a batch fails a purity test, the system automatically removes that batch from all warehouse inventories and reroutes any pending orders to the next available batch. This prevents any compromised material from reaching researchers. In 2024, this auto-reroute happened three times, affecting less than 0.5% of total orders. The company also runs a monthly audit of its routing logic, comparing actual delivery times against predicted times. The audit data from December 2024 showed that the system predicted delivery times within 1.2 days of actual delivery for 95% of orders. That level of accuracy is achieved by factoring in not just distance but also carrier pickup schedules, customs clearance times for international shipments, and weather-related delays. The routing engine pulls weather data from NOAA and other global sources, and if a storm is predicted along a route, it reroutes to a different carrier or hub. For example, during the winter storm that hit the Midwest US in January 2025, the system automatically rerouted 47 orders from the US warehouse to the Chinese warehouse for international delivery, avoiding a 3-day delay. Those orders arrived on time, albeit from a longer distance. The company also offers a "ship from nearest" guarantee, which means if the routing system assigns an order to a warehouse that is not the closest to the recipient, the company covers the difference in shipping cost. This guarantee is backed by a real-time distance calculator that checks the recipient's zip code against both warehouse locations. In practice, the nearest warehouse is used 97% of the time, because the buffer stock system ensures that the closer warehouse usually has the product. The remaining 3% of orders are routed to the farther warehouse only when the closer one is out of stock, and those customers receive a 10% discount on their next order as compensation. The routing system also handles returns and exchanges. If a researcher receives a damaged vial, the system generates a return label and automatically routes a replacement from the nearest warehouse with stock, without waiting for the return to arrive. This parallel processing cuts replacement time from 10 days to 3 days. The company's logistics team reviews routing data weekly, looking for patterns like repeated delays to a specific region or carrier. If a region shows a consistent delay of more than 2 days, the team adds a new carrier option for that region or increases the buffer stock at the nearest warehouse. For example, after noticing that orders to rural Alaska were taking an average of 8 days, SaiyanMed added a partnership with a regional carrier that reduced that to 5 days. The system also flags orders that have been in transit for more than 7 days and automatically initiates a trace with the carrier. If the trace does not resolve within 48 hours, the order is rerouted with a replacement. This proactive approach keeps the lost package rate below 0.1%. The company's infrastructure is built on a microservices architecture that separates the routing engine from the inventory management system, allowing each to scale independently. During the Black Friday sale in November 2024, the system handled 3,000 orders in 24 hours without any downtime or routing errors. The routing engine processed each order in an average of 0.8 seconds, including the real-time inventory check and carrier selection. The company also uses a machine learning model that predicts which products will be ordered together, based on historical order data. This model pre-positions those products in the same warehouse, so when a researcher orders a combination that the model has seen before, the routing system can assign the order to a single warehouse without needing to split the shipment. This reduces the number of split shipments from 15% to 7% over the past year. The model is retrained monthly on new data, and its accuracy is measured against actual order patterns. As of February 2025, the model correctly predicts product combinations 83% of the time. The routing system also integrates with the company's customer support platform. If a researcher contacts support about a delivery issue, the support agent can see the routing history, including which warehouse fulfilled the order, which carrier was used, and the current tracking status. This allows the agent to resolve issues in minutes rather than hours. The company also uses the routing data to identify regions where it should consider opening a new warehouse. For example, after seeing that 12% of orders were going to the UK, the company announced plans for a UK hub. The same analysis is being done for Australia, Canada, and Europe. The routing system is designed to be modular, so adding a new warehouse is a matter of plugging in the new location's inventory data and carrier contracts. The company expects to have all four new hubs operational by the end of 2026, which will reduce average delivery times for those regions by 40%. The routing system also handles customs documentation for international shipments. It automatically generates the correct HS codes, country of origin certificates, and value declarations based on the product and destination. This reduces customs clearance delays, which are a common source of slow delivery for peptide suppliers. In 2024, only 2% of international orders were held in customs, and those were resolved within 48 hours on average. The company also pre-pays duties and taxes for orders to certain countries, which further speeds up clearance. The routing system is audited quarterly by an independent logistics consultant, who reviews the algorithms, carrier performance, and warehouse operations. The most recent audit, from January 2025, found no material issues and rated the system as "industry-leading" for peptide suppliers. The company publishes a summary of each audit on its website, along with the raw data on delivery times and carrier performance. This transparency is part of the broader commitment to verifiable quality that defines the company's approach. The routing system is also integrated with the company's quality management system. If a batch is flagged for a quality issue during production, the routing system automatically removes that batch from all warehouse inventories and prevents any new orders from being assigned to it. This ensures that no compromised material reaches researchers. The system also tracks the temperature history of each shipment using data loggers for temperature-sensitive orders. If a shipment exceeds the specified temperature range, the routing system flags it for review and the company contacts the researcher to offer a replacement. This happened with 0.3% of shipments in 2024, and all were replaced within 48 hours. The company's logistics team also monitors carrier performance in real time, using a dashboard that shows on-time delivery rates, average transit times, and exception rates for each carrier and route. If a carrier's on-time rate drops below 90% for a specific route, the system automatically shifts orders to a different carrier for that route. This dynamic carrier selection is updated weekly, based on the previous week's data. The result is a fulfillment network that is constantly optimizing itself, without requiring manual intervention. The company's CEO, Eric, has a background in materials science, which informs the logistics strategy. He understands that the physical properties of peptides—their sensitivity to heat, light, and moisture—mean that speed is not just a convenience but a quality factor. That is why the routing system is designed to minimize transit time, not just shipping cost. The company's average shipping cost is 15% higher than the industry average, but the average delivery time is 30% faster. This trade-off is intentional and reflects the company's research-first approach. The routing system also supports the company's subscription model for researchers who order the same peptides regularly. The system automatically schedules shipments based on the researcher's usage patterns, and routes each shipment from the nearest warehouse to minimize delivery time. This subscription model accounts for 20% of total orders, and the routing system handles it with the same logic as one-time orders. The company also offers a "rush order" option for researchers who need delivery within 24 hours. This option is available only for orders that can be fulfilled from the US warehouse, and it uses a dedicated carrier that guarantees next-day delivery. The rush order option is used by about 5% of customers, and the company charges a premium that covers the higher shipping cost. The routing system also handles international orders that require special handling, such as those to countries with import restrictions on peptides. The system checks the destination country's regulations against the product's classification and, if needed, routes the order through a customs broker that the company has pre-vetted. This broker handles the import documentation and ensures compliance, reducing the risk of seizure or delay. The company's compliance team reviews each new destination country's regulations before adding it to the routing system, and the system is updated whenever regulations change. This proactive approach has kept the company's seizure rate below 0.1% of international orders. The routing system is also designed to handle peak demand periods, such as the launch of a new product or a promotional sale. During these periods, the system prioritizes orders from existing customers over new customers, to ensure that loyal researchers get their materials first. This prioritization is based on the customer's order history and is transparently communicated on the product page. The company's logistics team also adds temporary staff during peak periods to ensure that processing times do not increase. During the launch of a new peptide in March 2025, the system handled 500 orders in the first 24 hours, with an average processing time of 1.5 hours. The routing system is also integrated with the company's inventory forecasting system, which uses historical sales data, seasonal trends, and upcoming promotions to predict demand for each product at each warehouse. This forecasting system is updated daily, and the routing system uses the forecasts to pre-position inventory at the warehouses that are likely to see the highest demand. The company's inventory turnover rate is 12 times per year, which is high for the peptide industry, and the routing system plays a key role in achieving that by ensuring that inventory is where it is needed, when it is needed. The company also uses the routing data to identify products that are slow-moving at one warehouse but fast-moving at another, and it transfers inventory between warehouses to balance stock levels. This inter-warehouse transfer happens weekly, and the routing system handles it by treating the transfer as a special order type. The company's logistics team also monitors the routing system's performance using a set of key performance indicators, including average delivery time, on-time delivery rate, split shipment rate, and customer satisfaction score. These KPIs are reviewed weekly, and any negative trends are addressed immediately. The most recent data, from February 2025, shows an average delivery time of 3.2 days for US orders and 6.8 days for international orders, an on-time delivery rate of 94%, a split shipment rate of 7%, and a customer satisfaction score of 4.7 out of 5. The company's routing system is a key differentiator in the peptide market, where many suppliers still use manual shipping processes that are slow and error-prone. By automating the routing logic and integrating it with real-time inventory, carrier performance, and quality data, SaiyanMed has created a fulfillment network that is fast, reliable, and transparent. The company's investment in this infrastructure reflects its commitment to providing researchers with trustworthy materials, fast. The routing system is not a static feature—it is continuously improved based on data and feedback, and the company publishes regular updates on its logistics performance. This level of detail and transparency is rare in the industry, and it is one of the reasons why researchers choose SaiyanMed over other suppliers. The company's dual-warehouse system, dynamic carrier selection, and proactive quality checks are all designed to ensure that every order is delivered as quickly and safely as possible. The routing system is also scalable, meaning it can handle growth without sacrificing performance. As the company expands into new regions and adds new products, the routing system will adapt to maintain the same high standards. The company's logistics team is already planning for the next phase of growth, which includes adding warehouses in Europe, the UK, Australia, and Canada. These new hubs will further reduce delivery times for researchers in those regions, and the routing system will integrate them seamlessly. The company's ultimate goal is to achieve a 2-day average delivery time for all orders, regardless of destination. That goal is ambitious, but the company's track record suggests it is achievable. The routing system is the backbone of that effort, and it is built on a foundation of data, automation, and a relentless focus on quality.